Home › Research › Treatments
Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease
Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST.. Journal of neurology, neurosurgery, and psychiatry, 2002-03-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To describe the effect of cholinesterase inhibitors (CEIs) on the natural course of Alzheimer's disease (AD). Methods The short and long term effects of CEIs were evaluated in 135 patients with probable Alzheimer's disease relative to 135 patients who were never exposed to CEIs matched by age, education, duration of the symptoms, and cognitive status. We measured 1 year change in cognitive and functional performance, and the likelihood of arriving at each of four end points: (1) mini mental state examination (MMSE) of 9 or lower, (2) Blessed dementia rating scale for activities of daily living of 12 or higher, (3) nursing home admission, and (4) death, over an average 3 years of observation (36.7 (SD 21.5) months).
What this study adds
Evidence grade: Low
The record lists 135 participants. This study compared 135 Alzheimer's patients taking cholinesterase inhibitors with 135 matched patients never exposed to them, measuring cognitive and functional change and outcomes such as nursing home admission and death over about three years. It examined whether these existing drugs alter the course of the disease, not whether they cure or prevent it.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lopez, O. L., Becker, J. T., Wisniewski, S., Saxton, J., Kaufer, D. I., & DeKosky, S. T. (2002). Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp.72.3.310
Vancouver
Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry. 2002. doi:10.1136/jnnp.72.3.310. PMID: 11861686.
BibTeX
@article{lopez2002-11861686,
author = {Lopez, O. L. and Becker, J. T. and Wisniewski, S. and Saxton, J. and Kaufer, D. I. and DeKosky, S. T.},
title = {{Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease}},
journal = {Journal of neurology, neurosurgery, and psychiatry},
year = {2002},
doi = {10.1136/jnnp.72.3.310},
pmid = {11861686},
url = {https://doi.org/10.1136/jnnp.72.3.310}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Methods The short and long term effects of CEIs were evaluated in 135 patients with probable Alzheimer's disease relative to 135 patients who were never exposed to CEIs matched by age, education, duration of the symptoms, and cognitive status.
- We measured 1 year change in cognitive and functional performance, and the likelihood of arriving at each of four end points: (1) mini mental state examination (MMSE) of 9 or lower, (2) Blessed dementia rating scale for activities of daily living of 12 or higher, (3) nursing home admission, and (4) death, over an average 3 years of observation (36.7 (SD 21.5) months).
- Results Patients on CEIs were better cognitively and functionally after 1 year compared with those patients who never used CEIs.
- A proportional hazard analysis with CEI use as a time dependent covariate showed that the use of CEIs decreased the risk of nursing home admission.
Why it matters
This study compared 135 Alzheimer's patients taking cholinesterase inhibitors with 135 matched patients never exposed to them, measuring cognitive and functional change and outcomes such as nursing home admission and death over about three years. It examined whether these existing drugs alter the course of the disease, not whether they cure or prevent it.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Participants135
- Evidence strengthLow
How this study scored 50/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of neurology, neurosurgery, and psychiatry) |
| Journal's citation record | 3 / 4 | Journal of Neurology Neurosurgery & Psychiatry: journal h-index 336 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2002 — older than 20 years, still counted |
| Sample size | 2 / 4 | 135 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 255 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.8 citations a year over 26 year(s) since 2002 |
| Impact for its field and year | 4 / 6 | Cited 16.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 12 other studies in this library |
| Still being cited | 1 / 4 | Cited 10 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Oscar L. López: h-index 126 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Pittsburgh: institution h-index 1,470 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 11861686) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 16.
Later studies that cite this one
12 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Treatments from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.